EIV Capital is the famous VC, which was founded in 2009. The leading representative office of defined VC is situated in the Houston. The venture was found in North America in United States.
The important activity for fund was in 2017. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The typical startup value when the investment from EIV Capital is 10-50 millions dollars. Considering the real fund results, this VC is 63 percentage points more often commits exit comparing to other organizations.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Glycos Biotechnologies. Among the most popular fund investment industries, there are Biotechnology, Energy.
This organization was formed by Anthony Annunziato. Besides them, we counted 5 critical employees of this fund in our database.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the EIV Capital, startups are often financed by DFJ, Mercury Fund. The meaningful sponsors for the fund in investment in the same round are Mercury Fund, Gideon Hixon Fund, Draper Nexus Ventures. In the next rounds fund is usually obtained by Mercury Fund, DFJ.
Related Funds
Funds with similar focus
Fund Name | Location |
Alchemy Partners | England, London, United Kingdom |
and factory | Japan, Tokyo |
Atmos Ventures | California, Palo Alto, United States |
Bank of St. Elizabeth | Missouri, Saint Elizabeth, United States |
Bright Stone | Beijing, Beijing, China |
Frontier Digital Ventures | Kuala Lumpur, Malaysia |
Gemini Investors | Massachusetts, United States, Wellesley |
Kunlun Fund | China, Hangzhou, Zhejiang |
Level One Partners | - |
LGB & Co | England, London, United Kingdom |
Maxygen | California, Redwood City, United States |
Metellus | Switzerland, Zurich, Zurich |
NetEase Capital | Beijing, Beijing, China |
Nina Capital | Barcelona, Catalonia, Spain |
Polymatter | France, Ile-de-France, Paris |
Rainmakers | California, San Francisco, United States |
Rebel Foods | India, Maharashtra, Pune |
The Pearse Lyons Accelerator | County Dublin, Dublin, Ireland |
TriWise Capital | China, Guangdong, Shenzhen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Glycos Biotechnologies | $4M | 20 Oct 2010 | Houston, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Glycos Biotechnologies | $4M | 20 Oct 2010 | Houston, Texas, United States |